D.A. Clump

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava et al. · Cancer Research · 2017 · 252 citations · Full text

Life Sciences, Immunology, Oncology +17

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni, William E. Gooding et al. · OncoImmunology · 2019 · 168 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

John A. Vargo, Robert L. Ferris, James Ohr et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 153 citations

Medicine, Oncology, Radiation Oncology +7

Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival

Scott Glaser, Steven F. Mandish, Beant S. Gill et al. · Head & Neck · 2016 · 129 citations

Medicine, Oncology, Surgery +17

Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer

Philip Sutera, D.A. Clump, Ronny Kalash et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 83 citations

Medicine, Oncology, Radiation Oncology +12